bcl-2 expression in plasma cells from neoplastic gammopathies and reactive plasmacytosis: a comparative study.
Data up to Jan 2025
Total Citations Per Year
Abstract
References (29)
Nonparametric Estimation from Incomplete Observations
1992 • 45,923 citations
Evaluation of survival data and two new rank order statistics arising in its consideration.
1966 • 7,595 citations
Immunoenzymatic labeling of monoclonal antibodies using immune complexes of alkaline phosphatase and monoclonal anti-alkaline phosphatase (APAAP complexes).
1984 • 3,268 citations
A clinical staging system for multiple myeloma correlation of measured myeloma cell mass with presenting clinical features, response to treatment, and survival
1975 • 3,051 citations
Cloning of the Chromosome Breakpoint of Neoplastic B Cells with the t(14;18) Chromosome Translocation
1984 • 1,761 citations
Molecular thanatopsis: a discourse on the BCL2 family and cell death
1996 • 1,412 citations
Bcl-2 initiates a new category of oncogenes: regulators of cell death
1992 • 1,078 citations
Deregulated Bcl-2 gene expression selectively prolongs survival of growth factor-deprived hemopoietic cell lines.
1990 • 926 citations
Bcl-2 oncoprotein blocks chemotherapy-induced apoptosis in a human leukemia cell line
1993 • 898 citations
Progression from lymphoid hyperplasia to high-grade malignant lymphoma in mice transgenic for the t(14;18)
1991 • 876 citations
High expression of bcl-2 protein in acute myeloid leukemia cells is associated with poor response to chemotherapy
1993 • 738 citations
Prognostic significance of bcl-2 protein expression in aggressive non- Hodgkin's lymphoma. Groupe d'Etude des Lymphomes de l'Adulte (GELA)
1996 • 419 citations
Prognostic significance of BCL-2 expression and bcl-2 major breakpoint region rearrangement in diffuse large cell non-Hodgkin's lymphoma: a British National Lymphoma Investigation Study
1996 • 322 citations
Expression in Non-Hodgkin's Lymphoma of thebcl-2 Protein Associated with the t(14;18) Chromosomal Translocation
1988 • 292 citations
Relationship of p53, bcl-2, and Tumor Proliferation to Clinical Drug Resistance in Non-Hodgkin's Lymphomas
1997 • 230 citations
Clinical relevance of BCL-2 overexpression in childhood acute lymphoblastic leukemia
1996 • 211 citations
Growth- and differentiation-associated expression of bcl-2 in B-chronic lymphocytic leukemia cells
1992 • 206 citations
p53 and bcl-2 expression in high-grade B-cell lymphomas: correlation with survival time
1994 • 188 citations
Immunolocalization of the Bcl-2 protein within hematopoietic neoplasms
1991 • 174 citations
The relationship between bcl‐2 expression and response to chemotherapy in acute leukaemia
1994 • 165 citations
Expression of the bcl-2 gene in human multiple myeloma cell lines and normal plasma cells
1992 • 137 citations
REGULATION OF CLINICAL CHEMORESISTANCE BY bcl‐2 AND BAX ONCOPROTEINS IN B‐CELL CHRONIC LYMPHOCYTIC LEUKAEMIA
1996 • 133 citations
Preparation of peroxidase: antiperoxidase (PAP) complexes for immunohistological labeling of monoclonal antibodies.
1982 • 106 citations
Upregulated expression of BCL-2 in multiple myeloma cells induced by exposure to doxorubicin, etoposide, and hydrogen peroxide
1996 • 99 citations
Normal and neoplastic human plasma cells express bcl-2 antigen.
1991 • 47 citations
Bcl-2 protein expression is not related to short survival in multiple myeloma.
1995 • 36 citations
Bcl‐2 rearrangements with breakpoints in both vcr and mbr in non‐Hodgkin’s lymphomas and chronic lymphocytic leukaemia
1996 • 26 citations
Circulating Ki67 positive lymphocytes in multiple myeloma and benign monoclonal gammopathy.
1995 • 22 citations
Differential expression of cell proliferation regulatory proteins in B‐ and T‐lineage acute lymphoblastic leukaemias
1996 • 20 citations
Cited By (0)
No citing papers found in database